Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  HIV Infection

  Free Subscription


Articles published in Pediatr Infect Dis J

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    May 2024
  1. COMBS M, Johnson A, Abbotsford J, Bowen AC, et al
    Evaluation of Pediatric HIV Postexposure Prophylaxis Guideline Following Child Sexual Assault in Western Australia.
    Pediatr Infect Dis J. 2024 May 7. doi: 10.1097/INF.0000000000004370.
    PubMed     Abstract available


    March 2024
  2. GREYBE L, Barnabas S, Cotton M, Rose P, et al
    Cardiometabolic Risk Profiles of Adolescents Living With Perinatally Acquired HIV in South Africa.
    Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004340.
    PubMed     Abstract available


    February 2024
  3. NYAKATO P, Boulle A, Wood R, Eley B, et al
    Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records.
    Pediatr Infect Dis J. 2024 Feb 21. doi: 10.1097/INF.0000000000004281.
    PubMed     Abstract available


  4. MALIK F, Crichton S, Plotnikova Y, Latysheva I, et al
    Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe.
    Pediatr Infect Dis J. 2024 Feb 2. doi: 10.1097/INF.0000000000004271.
    PubMed     Abstract available


    January 2024
  5. AITCHESON N, Sacks E, Nyamundaya TH, Muchuchuti C, et al
    The Cascade of Care for Early Infant Diagnosis in Zimbabwe: Point of Care HIV Testing at Birth and 6-8 Weeks.
    Pediatr Infect Dis J. 2024 Jan 18. doi: 10.1097/INF.0000000000004198.
    PubMed     Abstract available


  6. GIFFORD A, Jayawardena N, Carlesse F, Lizarazo J, et al
    Pediatric Cryptococcosis.
    Pediatr Infect Dis J. 2024 Jan 15. doi: 10.1097/INF.0000000000004216.
    PubMed     Abstract available


  7. BEKKER A, Yang J, Wang J, Cotton MF, et al
    Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age.
    Pediatr Infect Dis J. 2024 Jan 4. doi: 10.1097/INF.0000000000004243.
    PubMed     Abstract available


    November 2023
  8. MECHA J, Escudero JN, Richardson BA, Maleche-Obimbo E, et al
    Maternal HIV Status and Risk of Infant Mycobacterium Tuberculosis Infection as Measured by Tuberculin Skin Test.
    Pediatr Infect Dis J. 2023 Nov 22. doi: 10.1097/INF.0000000000004190.
    PubMed     Abstract available


  9. EPALZA C, Valades-Alcaraz A, Gonzalez-Alba JM, Beltran-Pavez C, et al
    Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain.
    Pediatr Infect Dis J. 2023 Nov 3. doi: 10.1097/INF.0000000000004138.
    PubMed     Abstract available


  10. VONASEK BJ, Kumwenda T, Gumulira J, Nyirongo M, et al
    POINT-OF-CARE ULTRASOUND FOR TUBERCULOSIS IN YOUNG CHILDREN WITH SEVERE ACUTE MALNUTRITION.
    Pediatr Infect Dis J. 2023 Nov 1. doi: 10.1097/INF.0000000000004158.
    PubMed     Abstract available


    October 2023
  11. BELL HL, Santos R, Varshney N, Camacho-Gomez S, et al
    Sarcina ventriculi of the Esophagus and Stomach in a Pediatric Patient With Severe Gastroparesis.
    Pediatr Infect Dis J. 2023 Oct 17. doi: 10.1097/INF.0000000000004131.
    PubMed    


    July 2023
  12. CHABALA C, Turkova A, Kapasa M, LeBeau K, et al
    Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
    Pediatr Infect Dis J. 2023 Jul 20. doi: 10.1097/INF.0000000000004047.
    PubMed     Abstract available


  13. GILL MM, Herrera N, Guilaze R, Mussa A, et al
    Virologic Outcomes and ARV Switch Profiles 2 Years After National Rollout of Dolutegravir to Children Less Than 15 Years in Southern Mozambique.
    Pediatr Infect Dis J. 2023 Jul 6. doi: 10.1097/INF.0000000000004037.
    PubMed     Abstract available


    June 2023
  14. CHETTY T, Pillay A, Balakrishna Y, Reddy T, et al
    Healthcare-Associated Infections Drive Antimicrobial Prescribing in Pediatric Departments at Three Academic Hospitals in South Africa.
    Pediatr Infect Dis J. 2023 Jun 23. doi: 10.1097/INF.0000000000003954.
    PubMed     Abstract available


  15. DUNLOP JL, Tait CL, Njuguna C, Frost KM, et al
    A Single Question on Maternal HIV Status Can Improve Identification of Children Living With HIV in South Africa.
    Pediatr Infect Dis J. 2023 Jun 21. doi: 10.1097/INF.0000000000004007.
    PubMed     Abstract available


    May 2023
  16. WOLF HT, Amole C, Singh V, Penazzato M, et al
    One Step Closer to Ending AIDS in Children.
    Pediatr Infect Dis J. 2023 May 17. doi: 10.1097/INF.0000000000003964.
    PubMed    


  17. NAKIDDU NJ, Bakeera-Kitaka S, Musoke P
    Prevalence and Factors Associated With Delayed Puberty Among Adolescents on Boosted Protease Inhibitor-based Second-line Antiretroviral Therapy: A Cross-sectional Study at a Pediatric Infectious Diseases Clinic in Uganda.
    Pediatr Infect Dis J. 2023;42:407-411.
    PubMed     Abstract available


    April 2023
  18. MCKENZIE C, Schaaf HS, Croucamp R, Palmer M, et al
    Recurrent Tuberculosis Treatment Episodes in Children Presenting With Presumptive Pulmonary Tuberculosis in Cape Town, South Africa.
    Pediatr Infect Dis J. 2023 Apr 19. doi: 10.1097/INF.0000000000003922.
    PubMed     Abstract available


    March 2023
  19. DENOEUD-NDAM L, Stecker C, Andifasi P, Mushavi A, et al
    Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic.
    Pediatr Infect Dis J. 2023 Mar 20. doi: 10.1097/INF.0000000000003906.
    PubMed     Abstract available


  20. ROSE PC, De la Rey Nel E, Cotton MF, Otwombe K, et al
    Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens.
    Pediatr Infect Dis J. 2023 Mar 14. doi: 10.1097/INF.0000000000003904.
    PubMed     Abstract available


    February 2023
  21. OLBRICH L, Nliwasa M, Sabi I, Ntinginya NE, et al
    Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease (RaPaed-TB): A Diagnostic Accuracy Study for Pediatric Tuberculosis.
    Pediatr Infect Dis J. 2023 Feb 16:e003853. doi: 10.1097/INF.0000000000003853.
    PubMed     Abstract available


  22. SUTCLIFFE CG, Moyo N, Hamahuwa M, Mutanga JN, et al
    The Evolving Pediatric HIV Epidemic in Rural Southern Zambia: The Beneficial Impact of Advances in Prevention and Treatment at a District Hospital From 2007 to 2019.
    Pediatr Infect Dis J. 2023 Feb 15. doi: 10.1097/INF.0000000000003873.
    PubMed     Abstract available


  23. BACHA JM, Dlamini S, Anabwani F, Gwimile J, et al
    Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern Africa.
    Pediatr Infect Dis J. 2023 Feb 14. doi: 10.1097/INF.0000000000003878.
    PubMed     Abstract available


  24. DODI I, Romanini E, Veronese P, Cangelosi AM, et al
    Highly Active Antiretroviral Therapy in an Extremely Low Birth Weight Newborn With in Utero Transmission of HIV.
    Pediatr Infect Dis J. 2023 Feb 8. doi: 10.1097/INF.0000000000003857.
    PubMed     Abstract available


  25. GROSS J, Medley A, Rivadeneira E, Battey K, et al
    Considerations to Improve Pediatric HIV Testing and Close the Treatment Gap in 16 African Countries.
    Pediatr Infect Dis J. 2023;42:110-118.
    PubMed     Abstract available


    January 2023
  26. TOURE F, Etheredge GD, Brennan C, Parris K, et al
    Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Cote d'Ivoire Between 2012 and 2016.
    Pediatr Infect Dis J. 2023 Jan 23. doi: 10.1097/INF.0000000000003839.
    PubMed     Abstract available


  27. HRAPCAK S, Pals S, Itoh M, Peters N, et al
    HIV Viral Load Scale-up Among Children and Adolescents: Trends in Viral Load Suppression, Sample Type and Processing in 7 PEPFAR Countries, 2015-2018.
    Pediatr Infect Dis J. 2023 Jan 18. doi: 10.1097/INF.0000000000003824.
    PubMed     Abstract available


    November 2022
  28. VAN WARMERDAM J, Campigotto A, Bitnun A, MacDougall G, et al
    Invasive Pneumococcal Disease in High-Risk Children: A 10-Year Retrospective Study.
    Pediatr Infect Dis J. 2022 Nov 18. doi: 10.1097/INF.0000000000003748.
    PubMed     Abstract available


    October 2022
  29. WANG L, Kourtis AP, Wiener J, Chen L, et al
    Impact of Tenofovir Disoproxil Fumarate Use During Pregnancy on Maternal Bone Mineral Density.
    Pediatr Infect Dis J. 2022 Oct 11. pii: 00006454-990000000-00212.
    PubMed    


    September 2022
  30. KADAMBARI S, Evans C, Lyall H
    Congenital Infections: Priorities and Possibilities for Resource-limited Settings.
    Pediatr Infect Dis J. 2022 Sep 12. pii: 00006454-990000000-00191.
    PubMed    


  31. DESAI N, Jenkins CA, Zanoni B, Nmoh A, et al
    High Rates of Viral Suppression and Care Retention Among Youth Born Outside of the United States with Perinatally Acquired HIV.
    Pediatr Infect Dis J. 2022 Sep 8. pii: 00006454-990000000-00187.
    PubMed     Abstract available


  32. DUVENHAGE J, Draper HR, Garcia-Prats AJ, Winckler J, et al
    Hepatocellular Injury in Children Treated for Rifampicin-resistant Tuberculosis: Incidence, Etiology and Outcome.
    Pediatr Infect Dis J. 2022 Sep 6. pii: 00006454-990000000-00179.
    PubMed     Abstract available


    August 2022
  33. LIYANAGE M, Nikanjam M, McFadyen L, Vourvahis M, et al
    Maraviroc Population Pharmacokinetics Within the First 6 Weeks of Life.
    Pediatr Infect Dis J. 2022 Aug 9. pii: 00006454-990000000-00156.
    PubMed     Abstract available


    July 2022
  34. STEEGEN K, Levin L, Evans D, Technau KG, et al
    Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment.
    Pediatr Infect Dis J. 2022 Jul 20. pii: 00006454-990000000-00138.
    PubMed     Abstract available


  35. BERZOSA SANCHEZ A, Epalza C, Navarro ML, Alcolea S, et al
    SARS-CoV-2 Infection in Children and Adolescents Living With HIV in Madrid.
    Pediatr Infect Dis J. 2022 Jul 6. pii: 00006454-990000000-00119.
    PubMed     Abstract available


    May 2022
  36. KIRMSE B, Hobbs C, Aaron L, Montepiedra G, et al
    Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.
    Pediatr Infect Dis J. 2022 May 25. pii: 00006454-990000000-00083.
    PubMed     Abstract available


  37. JIANG M, Wang HM, Zhou GL, Chen YS, et al
    Invasive Salmonella Infections Among Children in Shenzhen, China: A Five-year Retrospective Review.
    Pediatr Infect Dis J. 2022 May 23. pii: 00006454-990000000-00079.
    PubMed     Abstract available


    April 2022
  38. HOFF CALEGARI L, Friedrich L, Rech Astolfi V, Kerber JM, et al
    The Impact of Maternal Syphilis and Associated Factors on HIV Vertical Transmission.
    Pediatr Infect Dis J. 2022 Apr 18. pii: 00006454-990000000-00049.
    PubMed     Abstract available


    February 2022
  39. BOETTIGER DC, An VT, Lumbiganon P, Wittawatmongkol O, et al
    Severe Recurrent Bacterial Pneumonia Among Children Living With HIV.
    Pediatr Infect Dis J. 2022 Feb 18. pii: 00006454-900000000-95532.
    PubMed     Abstract available


  40. DOLLFUS C, Le Chenadec J, Mandelbrot L, Tubiana R, et al
    Improved Hematologic Outcomes in HIV1-exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting.
    Pediatr Infect Dis J. 2022 Feb 7. pii: 00006454-900000000-95545.
    PubMed     Abstract available


  41. JACOBS TG, van Aerde KJ, Colbers A, Burger DM, et al
    Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure.
    Pediatr Infect Dis J. 2022;41:131-132.
    PubMed     Abstract available


    January 2022
  42. MALIK F, Malyuta R, Volokha A, Bailey H, et al
    Hepatitis C Virus Treatment Response to Direct-acting Antivirals Among Adolescents With HIV/HCV Coinfection: Real-world Data From Ukraine.
    Pediatr Infect Dis J. 2022 Jan 20. pii: 00006454-900000000-95560.
    PubMed     Abstract available


  43. MORREALE A, Dotta L, Vairo D, Bazzana T, et al
    When a Nontuberculous Mycobacterial Infection Reveals an Error of Immunity: A Single Center's Experience.
    Pediatr Infect Dis J. 2022 Jan 17. pii: 00006454-900000000-95554.
    PubMed     Abstract available


  44. GARCIA-BOYANO M, Chavez-Solorzano N, Layana-Coronel M, Soffe-Pazmino J, et al
    Determinants of Disclosure, Adherence and Viral Suppression in Children and Adolescents Living With HIV in Ecuador: A Cross-Sectional Study.
    Pediatr Infect Dis J. 2022 Jan 11. pii: 00006454-900000000-95566.
    PubMed     Abstract available


    December 2021
  45. KHAMADI S, Lwembe R, Maosa N, Maloba M, et al
    HIV Drug Resistance in Kenyan Infants Diagnosed With HIV and Their Mothers.
    Pediatr Infect Dis J. 2021 Dec 21. pii: 00006454-900000000-95584.
    PubMed     Abstract available


  46. ILLAN RAMOS M, Soto Sanchez B, Mazariegos Orellana D, Prieto Tato LM, et al
    Safety and Experience With Combined Antiretroviral Prophylaxis in Newborn at High-risk of Perinatal HIV Infection, in a Cohort of Mother Living With HIV-infant Pairs.
    Pediatr Infect Dis J. 2021;40:1096-1100.
    PubMed     Abstract available


    November 2021
  47. MUHAIRWE JA, Brown JA, Motaboli L, Nsakala BL, et al
    The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study Among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa.
    Pediatr Infect Dis J. 2021 Nov 30. pii: 00006454-900000000-95608.
    PubMed     Abstract available


  48. LOERINC L, Scheel A, Jordan-Thompson S, Gillespie S, et al
    Incidence, Reinfection, and Discrepancy Between Sexual Practice and Anatomic Site Positivity of Sexually Transmitted Infections in Youth With HIV.
    Pediatr Infect Dis J. 2021 Nov 9. pii: 00006454-900000000-95630.
    PubMed     Abstract available


    October 2021
  49. LI SNJ, Albert A, Piske M, Janssen PA, et al
    Higher Hospitalization Rates in Children Born HIV-exposed Uninfected in British Columbia, Canada, Between 1990 and 2012.
    Pediatr Infect Dis J. 2021 Oct 26. pii: 00006454-900000000-95644.
    PubMed     Abstract available


  50. MILLS A, Myers L, Raudenbush C, Vossen DA, et al
    A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use.
    Pediatr Infect Dis J. 2021 Oct 19. pii: 00006454-900000000-95652.
    PubMed     Abstract available


  51. SINGH RP, Adkison KK, Baker M, Parasrampuria R, et al
    Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children.
    Pediatr Infect Dis J. 2021 Oct 12. pii: 00006454-900000000-95623.
    PubMed     Abstract available


    September 2021
  52. PEREIRA NMD, Heath PT, Doerholt K, Almario-Hernandez AF, et al
    SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
    Pediatr Infect Dis J. 2021 Sep 28. pii: 00006454-900000000-95663.
    PubMed     Abstract available


  53. MILLER C, Daugherty R, McCulloch M, Stephens I, et al
    Immune Reconstitution Inflammatory Syndrome Complicating Cryptococcal Meningitis in a Pediatric Heart Transplant Patient.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95687.
    PubMed     Abstract available


  54. WEYLAND C, Mirani G, Gillespie SL, Paul ME, et al
    A Case of in utero Transmission of Drug-resistant HIV in the United States.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95685.
    PubMed     Abstract available


  55. HRAPCAK S, Bekele A, Ahmed J, Ayalew J, et al
    Finding Children Living With HIV in Low-prevalence Countries: HIV Prevalence and Testing Yield From 5 Entry Points in Ethiopia.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95684.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.